First Time Loading...

Cytek Biosciences Inc
NASDAQ:CTKB

Watchlist Manager
Cytek Biosciences Inc Logo
Cytek Biosciences Inc
NASDAQ:CTKB
Watchlist
Price: 6.38 USD -0.62% Market Closed
Updated: May 8, 2024

Cytek Biosciences Inc
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Cytek Biosciences Inc
Revenue Peer Comparison

Comparables:
TMO
DHR
WST
A
IQV

Competitive Revenue Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Cytek Biosciences Inc
NASDAQ:CTKB
Revenue
$193m
CAGR 3-Years
28%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Thermo Fisher Scientific Inc
NYSE:TMO
Revenue
$42.9B
CAGR 3-Years
10%
CAGR 5-Years
12%
CAGR 10-Years
13%
Danaher Corp
NYSE:DHR
Revenue
$43.7B
CAGR 3-Years
21%
CAGR 5-Years
21%
CAGR 10-Years
9%
West Pharmaceutical Services Inc
NYSE:WST
Revenue
$2.9B
CAGR 3-Years
8%
CAGR 5-Years
11%
CAGR 10-Years
8%
Agilent Technologies Inc
NYSE:A
Revenue
$6.7B
CAGR 3-Years
7%
CAGR 5-Years
6%
CAGR 10-Years
8%
IQVIA Holdings Inc
NYSE:IQV
Revenue
$15B
CAGR 3-Years
10%
CAGR 5-Years
8%
CAGR 10-Years
11%

Cytek Biosciences Inc
Revenue Breakdown

Breakdown by Geography
Cytek Biosciences Inc

Total Revenue: 193m USD
100%
United States: 102.1m USD
52.9%
EMEA: 53.2m USD
27.6%
Asia Pacific: 31.6m USD
16.4%
Other: 6.2m USD
3.2%
Show More
Show Less

Breakdown by Segments
Cytek Biosciences Inc

Total Revenue: 193m USD
100%
Product: 156.7m USD
81.2%
Service: 36.3m USD
18.8%

See Also

What is Cytek Biosciences Inc's Revenue?
Revenue
193m USD

Based on the financial report for Dec 31, 2023, Cytek Biosciences Inc's Revenue amounts to 193m USD.

What is Cytek Biosciences Inc's Revenue growth rate?
Revenue CAGR 3Y
28%

Over the last year, the Revenue growth was 18%. The average annual Revenue growth rates for Cytek Biosciences Inc have been 28% over the past three years .